We are live on ! Find out more
JUNS

Jupiter Neurosciences
JUNS

2 hedge funds and large institutions have $54.3K invested in Jupiter Neurosciences in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more ownership

Funds ownership: 0% → 0% (+0%)

Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citigroup
Citigroup
New York
+$45.3K
2
Morgan Stanley
Morgan Stanley
New York
+$5.28K

Top Sellers

No sellers this quarter

JUNS Hedge Fund Activity: Q4 2024 in Review

2 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Jupiter Neurosciences (JUNS) for Q4 2024, worth a combined $54.3K.

Buyers outnumbered sellers: 2 funds opened new JUNS positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Citigroup, opening a new position worth an estimated $45.3K.

  • 2 institutional investors held Jupiter Neurosciences (JUNS) as of Q4 2024, up from 0 in Q3 2024.
  • Funds reported $54.3K of Jupiter Neurosciences stock for Q4 2024.
  • 2 funds opened new Jupiter Neurosciences positions in Q4 2024 and 0 closed out, a net change of +2 holders.
  • The largest Jupiter Neurosciences buyer in Q4 2024 was Citigroup, an estimated $45.3K added.

Based on aggregated 13F filings for Q4 2024.